fig3

MRI for screening and surveillance for hepatocellular cancer in NAFLD and NASH

Figure 3. HCC in a patient with NASH using EOVIST, HBP agent. Non-contrast image cirrhotic liver with a low signal intensity mass; The arterial phase shows a vague non-rim enhancement; Portal venous phase with subtle washout; Transitional phase; HBP with clear washout.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/